# Influenza Vaccination in Hemodialysis Patients and Renal Transplant Recipients

> **NCT00776750** · PHASE4 · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 407 (actual)

## Conditions studied

- Hemodialysis
- Renal Transplantation

## Interventions

- **BIOLOGICAL:** trivalent split influenza vaccine

## Key facts

- **NCT ID:** NCT00776750
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2004-05
- **Final completion:** 2004-05
- **Target enrollment:** 407 (ACTUAL)
- **Last updated:** 2008-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00776750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00776750, "Influenza Vaccination in Hemodialysis Patients and Renal Transplant Recipients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00776750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*